Tandem Diabetes Care has responded to an FDA recall notice that the organization calls its "most serious" after hundreds of injuries have been reported.
New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...
New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...
“It is a natural evolution of our mission to bring the same AID technology that helped to make Tandem the #1 recommended insulin pump brand by both healthcare providers and people living with type 1 ...
Automated insulin delivery systems are safe, effective, and well-received by older adults with type 1 diabetes, challenging ...
“Innovations in insulin pump technology, including closed-loop systems and AI-driven glucose monitoring, are redefining diabetes care. The future lies in smart, patient-centric solutions ...
The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion ... hence its 'hybrid' status. "This technology is a significant ...
"The risk of diabetic ketoacidosis linked to continuous subcutaneous insulin infusion in type 1 diabetes has significantly ...
Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as airplane takeoffs and landings. “We request you ...
Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...
"It is a natural evolution of our mission to bring the same AID technology that helped to make Tandem the #1 recommended insulin pump brand by both healthcare providers and people living with type ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery (AID) algorithm, Control ...